Human F13B (Coagulation Factor 13 B Polypeptide) ELISA Kit (HUES01909)
- SKU:
- HUES01909
- Product Type:
- ELISA Kit
- Size:
- 96 Assays
- Uniprot:
- P05160
- Sensitivity:
- 1.88ng/mL
- Range:
- 3.13-200ng/mL
- ELISA Type:
- Sandwich
- Synonyms:
- F13B , FXIIIB
- Reactivity:
- Human
- Sample Type:
- Serum, plasma and other biological fluids
- Research Area:
- Cardiovascular
Description
Human F13B (Coagulation Factor 13 B Polypeptide) ELISA Kit
The Human F13B (Coagulation Factor 13 B polypeptide) ELISA Kit is specifically designed for the accurate measurement of F13B levels in human serum, plasma, and cell culture supernatants. This kit offers exceptional sensitivity and specificity, ensuring dependable and reproducible results for various research applications.Coagulation Factor 13 B polypeptide is an important component in the blood coagulation cascade, playing a key role in wound healing and clot formation. Dysregulation of this protein has been implicated in various hematological disorders and coagulopathies, highlighting its significance as a biomarker for studying these conditions and developing potential treatments.
With its advanced technology and precision, the Human F13B ELISA Kit from Assaygenie provides researchers with a valuable tool for investigating the role of F13B in health and disease, ultimately leading to a better understanding of coagulation processes and potential therapeutic interventions.
Assay type: | Sandwich |
Format: | 96T |
Assay time: | 4.5h |
Reactivity: | Human |
Detection Method: | Colormetric |
Detection Range: | 3.13-200 ng/mL |
Sensitivity: | 1.88 ng/mL |
Sample Volume Required Per Well: | 100µL |
Sample Type: | Serum, plasma and other biological fluids |
Specificity: | This kit recognizes Human F13B in samples. No significant cross-reactivity or interference between Human F13B and analogues was observed. |
This ELISA kit uses Sandwich-ELISA as the method. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human F13B. Standards or samples are added to the appropriate micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human F13B and Avidin-Horseradish Peroxidase (HRP) conjugate are added to each micro plate well successively and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human F13B, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by adding Stop Solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human F13B. The concentration of Human F13B in samples can be calculated by comparing the OD of the samples to the standard curve.
UniProt Protein Function: | F13B: The B chain of factor XIII is not catalytically active, but is thought to stabilize the A subunits and regulate the rate of transglutaminase formation by thrombin. Defects in F13B are the cause of factor XIII subunit B deficiency (FA13BD). FA13BD is an autosomal recessive disorder characterized by a life-long bleeding tendency, impaired wound healing and spontaneous abortion in affected women. |
UniProt Protein Details: | Protein type:Secreted, signal peptide; Secreted Chromosomal Location of Human Ortholog: 1q31-q32. 1 Cellular Component: extracellular region Biological Process: blood coagulation Disease: Factor Xiii, B Subunit, Deficiency Of |
NCBI Summary: | This gene encodes coagulation factor XIII B subunit. Coagulation factor XIII is the last zymogen to become activated in the blood coagulation cascade. Plasma factor XIII is a heterotetramer composed of 2 A subunits and 2 B subunits. The A subunits have catalytic function, and the B subunits do not have enzymatic activity and may serve as a plasma carrier molecules. Platelet factor XIII is comprised only of 2 A subunits, which are identical to those of plasma origin. Upon activation by the cleavage of the activation peptide by thrombin and in the presence of calcium ion, the plasma factor XIII dissociates its B subunits and yields the same active enzyme, factor XIIIa, as platelet factor XIII. This enzyme acts as a transglutaminase to catalyze the formation of gamma-glutamyl-epsilon-lysine crosslinking between fibrin molecules, thus stabilizing the fibrin clot. Factor XIII deficiency is classified into two categories: type I deficiency, characterized by the lack of both the A and B subunits; and type II deficiency, characterized by the lack of the A subunit alone. These defects can result in a lifelong bleeding tendency, defective wound healing, and habitual abortion. [provided by RefSeq, Jul 2008] |
UniProt Code: | P05160 |
NCBI GenInfo Identifier: | 145559473 |
NCBI Gene ID: | 2165 |
NCBI Accession: | P05160. 3 |
UniProt Secondary Accession: | P05160,Q5VYL5, A8K3E5, |
UniProt Related Accession: | P05160 |
Molecular Weight: | 75,511 Da |
NCBI Full Name: | Coagulation factor XIII B chain |
NCBI Synonym Full Names: | coagulation factor XIII B chain |
NCBI Official Symbol: | F13B |
NCBI Official Synonym Symbols: | FXIIIB |
NCBI Protein Information: | coagulation factor XIII B chain |
UniProt Protein Name: | Coagulation factor XIII B chain |
UniProt Synonym Protein Names: | Fibrin-stabilizing factor B subunit; Protein-glutamine gamma-glutamyltransferase B chain; Transglutaminase B chain |
Protein Family: | Coagulation factor |
UniProt Gene Name: | F13B |
UniProt Entry Name: | F13B_HUMAN |
As the OD values of the standard curve may vary according to the conditions of the actual assay performance (e. g. operator, pipetting technique, washing technique or temperature effects), the operator should establish a standard curve for each test. Typical standard curve and data is provided below for reference only.
Concentration (ng/mL) | O.D | Average | Corrected |
200 | 2.291 2.293 | 2.292 | 2.22 |
100 | 1.49 1.546 | 1.518 | 1.446 |
50 | 0.888 0.864 | 0.876 | 0.804 |
25 | 0.356 0.378 | 0.367 | 0.295 |
12.5 | 0.258 0.234 | 0.246 | 0.174 |
6.25 | 0.163 0.157 | 0.16 | 0.088 |
3.13 | 0.112 0.124 | 0.118 | 0.046 |
0 | 0.065 0.079 | 0.072 | -- |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, mid range and high level Human F13B were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, mid range and high level Human F13B were tested on 3 different plates, 20 replicates in each plate.
Intra-assay Precision | Inter-assay Precision | |||||
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (ng/mL) | 9.29 | 20.51 | 93.71 | 8.85 | 18.57 | 93.53 |
Standard deviation | 0.59 | 1.05 | 3.92 | 0.47 | 1.08 | 4.96 |
C V (%) | 6.35 | 5.12 | 4.18 | 5.31 | 5.82 | 5.30 |
Recovery
The recovery of Human F13B spiked at three different levels in samples throughout the range of the assay was evaluated in various matrices.
Sample Type | Range (%) | Average Recovery (%) |
Serum (n=5) | 86-100 | 91 |
EDTA plasma (n=5) | 97-109 | 102 |
Cell culture media (n=5) | 87-99 | 94 |
Linearity
Samples were spiked with high concentrations of Human F13B and diluted with Reference Standard & Sample Diluent to produce samples with values within the range of the assay.
Serum (n=5) | EDTA plasma (n=5) | Cell culture media (n=5) | ||
1:2 | Range (%) | 95-111 | 85-98 | 85-99 |
Average (%) | 101 | 91 | 91 | |
1:4 | Range (%) | 87-98 | 84-97 | 84-96 |
Average (%) | 92 | 90 | 91 | |
1:8 | Range (%) | 88-101 | 81-93 | 88-101 |
Average (%) | 95 | 87 | 95 | |
1:16 | Range (%) | 89-102 | 83-98 | 82-95 |
Average (%) | 95 | 89 | 88 |
An unopened kit can be stored at 4°C for 1 month. If the kit is not used within 1 month, store the items separately according to the following conditions once the kit is received.
Item | Specifications | Storage |
Micro ELISA Plate(Dismountable) | 8 wells ×12 strips | -20°C, 6 months |
Reference Standard | 2 vials | |
Concentrated Biotinylated Detection Ab (100×) | 1 vial, 120 µL | |
Concentrated HRP Conjugate (100×) | 1 vial, 120 µL | -20°C(shading light), 6 months |
Reference Standard & Sample Diluent | 1 vial, 20 mL | 4°C, 6 months |
Biotinylated Detection Ab Diluent | 1 vial, 14 mL | |
HRP Conjugate Diluent | 1 vial, 14 mL | |
Concentrated Wash Buffer (25×) | 1 vial, 30 mL | |
Substrate Reagent | 1 vial, 10 mL | 4°C(shading light) |
Stop Solution | 1 vial, 10 mL | 4°C |
Plate Sealer | 5 pieces | |
Product Description | 1 copy | |
Certificate of Analysis | 1 copy |
- Set standard, test sample and control (zero) wells on the pre-coated plate and record theirpositions. It is recommended to measure each standard and sample in duplicate. Note: addall solutions to the bottom of the plate wells while avoiding contact with the well walls. Ensuresolutions do not foam when adding to the wells.
- Aliquot 100 µL of standard solutions into the standard wells.
- Add 100 µL of Sample / Standard dilution buffer into the control (zero) well.
- Add 100 µL of properly diluted sample (serum, plasma, tissue homogenates and otherbiological fluids) into test sample wells.
- Cover the plate with the sealer provided in the kit and incubate for 90 min at 37 °C.
- Aspirate the liquid from each well, do not wash. Immediately add 100 µL of BiotinylatedDetection Ab working solution to each well. Cover the plate with a plate seal and gently mix. Incubate for 1 hour at 37 °C.
- Aspirate or decant the solution from the plate and add 350 µL of wash buffer to each welland incubate for 1-2 minutes at room temperature. Aspirate the solution from each well andclap the plate on absorbent filter paper to dry. Repeat this process 3 times. Note: a microplatewasher can be used in this step and other wash steps.
- Add 100 µL of HRP Conjugate working solution to each well. Cover with a plate seal andincubate for 30 min at 37 °C.
- Aspirate or decant the solution from each well. Repeat the wash process for five times asconducted in step 7.
- Add 90 µL of Substrate Reagent to each well. Cover with a new plate seal and incubate forapproximately 15 min at 37 °C. Protect the plate from light. Note: the reaction time can beshortened or extended according to the actual color change, but not by more than 30min.
- Add 50 µL of Stop Solution to each well. Note: Adding the stop solution should be done inthe same order as the substrate solution.
- Determine the optical density (OD value) of each well immediately with a microplate readerset at 450 nm.